Bold integration of biomedical and behavioral science will result in successful HIV Prevention. Our Prevention Core leadership includes Co-Directors Michelle Lally, MD, MSc and Larry Brown, MD. With a shared passion for HIV prevention and a shared vision of novel """"""""biobehavioral"""""""" approaches to HIV prevention. Dr. Lally investigates HIV Vaccines and PrEP, and Dr. Brown's extensive experience and expertise is in behavioral science. Additional Core Faculty, all superb and each committed to the combination of biomedical and behavioral science, include Michael Carey, PhD, Director of Centers for Behavioral and Preventive Medicine at Lifespan, Don Operario, PhD, Director of Graduate Program in Behavioral and Social Sciences Intervention, Brown Program in Public Health, Kate Morrow, PhD (microbicide acceptability). Curt Beckwith, MD (HIV testing and treatment among prisoners and other marginalized populations), Steve Hong, MD (international HIV primary and secondary prevention), and Kenneth Mayer, MD (broad HIV prevention experience and expertise). A red ribbon imprinted with """"""""B &B"""""""" is our Core's logo, which has been effective at promoting the Biomedical &Behavioral branding of our Prevention Core.
Our Aims are to provide HIV prevention researchers (students /junior investigators / experienced investigators) with consultation and mentorship, education and training, and support services that are consistently inclusive of both biomedical and behavioral science.
Aims will be achieved through effective advertising of our services, individual consultations and ongoing mentorship of junior investigators, education and training (on a weekly, monthly, quarterly, or annual basis), and community collaboration. Expected outcomes are sustained and increased funding for research related to HIV prevention among our investigators, continued growth in the number of Core users, increased frequency of use of Core services, and a steady increase in the number of individual prevention projects that clearly incorporate both biomedical and behavioral science. Outcomes will be tracked and measured, and adjustments will be made to our approaches as necessary to assure that outcomes are achieved.

Public Health Relevance

HIV is a preventable infection, and AIDS is a preventable disease;yet prevention success can be achieved only when effective biological products are combined with requisite behavioral methodologies. The Prevention Core proposes to strategically support HIV prevention efforts with a combination of biomedical and behavioral science through the provision of expert

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI042853-15
Application #
8292692
Study Section
Special Emphasis Panel (ZAI1-RRS-A (J1))
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
15
Fiscal Year
2012
Total Cost
$144,981
Indirect Cost
$45,679
Name
Miriam Hospital
Department
Type
DUNS #
063902704
City
Providence
State
RI
Country
United States
Zip Code
02906
Lee, Hana; Wu, Xiaotian K; Genberg, Becky L et al. (2018) Beyond binary retention in HIV care: predictors of the dynamic processes of patient engagement, disengagement, and re-entry into care in a US clinical cohort. AIDS 32:2217-2225
Whiteley, Laura B; Brown, Larry K; Curtis, Virginia et al. (2018) Publicly Available Internet Content as a HIV/STI Prevention Intervention for Urban Youth. J Prim Prev :
Sackey, Joachim; Zhang, Fang Fang; Rogers, Beatrice et al. (2018) Food security and dietary diversity are associated with health related quality of life after 6 months of follow up among people living with HIV in Accra, Ghana. AIDS Care 30:1567-1571
Rodriguez, Carla V; Rubenstein, Kevin B; Linas, Benjamin et al. (2018) Increasing hepatitis C screening in a large integrated health system: science and policy in concert. Am J Manag Care 24:e134-e140
Olney, Jack J; Eaton, Jeffrey W; Braitstein, Paula et al. (2018) Optimal timing of HIV home-based counselling and testing rounds in Western Kenya. J Int AIDS Soc 21:e25142
Gnatienko, Natalia; Freiberg, Matthew S; Blokhina, Elena et al. (2018) Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia. HIV Clin Trials 19:101-111
Brinkley-Rubinstein, Lauren; McKenzie, Michelle; Macmadu, Alexandria et al. (2018) A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend 184:57-63
Sam, Soya S; Caliendo, Angela M; Ingersoll, Jessica et al. (2018) Performance evaluation of the Aptima HSV-1 and 2 assay for the detection of HSV in cutaneous and mucocutaneous lesion specimens. J Clin Virol 99-100:1-4
Lally, Michelle A; van den Berg, Jacob J; Westfall, Andrew O et al. (2018) HIV Continuum of Care for Youth in the United States. J Acquir Immune Defic Syndr 77:110-117
Schechter-Perkins, Elissa M; Miller, Nancy S; Hall, Jon et al. (2018) Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program. Acad Emerg Med :

Showing the most recent 10 out of 806 publications